Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Normal Range for Maximal Sniff Diaphragm Thickening Fraction

NCT03129386 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03129386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03129386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Normal Range for Maximal Sniff Diaphragm Thickening Fraction
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
June 8, 2016
Completion date
January 31, 2019
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diaphragm